Consistency of response across subgroups of patients with psoriasis treated with guselkumab: Results from the VOYAGE 1 and 2 trials - 11/08/17
Andrew Blauvelt, MD, Oregon Medical Research Center; Kristian Reich, MD, Dermatologikum Hamburg; Kim A. Papp, MD, K Papp Clinical Research and Probity Research, Inc.; Christopher E.M. Griffiths, MD, Dermatology Centre, Salford Royal Hospital, U of Manchester, Manchester Academic Health Science Cntr; April W. Armstrong, MD, University of Southern California; Peter Foley, MD, The University of Melbourne, St. Vincent’s Hospital, Melbourne and Skin & Cancer Foundation Inc.; Yaung-Kaung Shen, PhD, Janssen Research & Development, LLC; Alexa B. Kimball, MD, Depart of Dermatology, Harvard Medical School; Kenneth B. Gordon, MD, Northwestern University, Feinberg School of Medicine
Le texte complet de cet article est disponible en PDF. Commercial support: Janssen Research & Development, LLC. sponsored this study 100%. |
Vol 76 - N° 6S1
P. AB83 - juin 2017 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?